Influenza virus hemagglutinin protein H1 (HA (specifically H1 subtype))

The **Influenza virus hemagglutinin protein H1** is a trimeric glycoprotein found on the surface of influenza A virions, most notably in H1N1 strains[1][2]. It is composed of three identical subunits, each cleaved into an HA1 (receptor-binding globular head) and HA2 (fusion-inducing stem domain)[3][4]. HA mediates two essential steps in viral infection: binding to sialic acid–containing receptors on host cells (conferring host-range specificity) and promoting fusion of the viral envelope with the endosomal membrane after uptake, which allows release of viral RNA into the host cytoplasm[1][2][3][4]. HA is also the primary antigenic determinant of influenza viruses and the main target of neutralizing antibodies and vaccines[4]. The antigenic properties and sequence diversity of H1 have made it a key determinant in both seasonal flu outbreaks and pandemics, with variation due to antigenic drift and shift posing significant challenges for vaccine design and efficacy[4][5].

Other names

Hemagglutinin (H1)HA (H1)Influenza H1 hemagglutinin proteinH1 HA

Neutralizing antibodies: Bind to HA (globular head or stem/stalk domain), block receptor binding or inhibit conformational changes needed for membrane fusion, directly neutralizing viral infectivity[4]. Vaccines: Elicit protective immune response through presentation of HA epitopes, stimulating production of neutralizing antibodies[4].